View Post

Study identifies predictors of immunotherapy response in head and neck cancer

In In The News by Barbara Jacoby

Source: Dana-Farber Cancer Institute From: Redington Newsdesk Dana-Farber Cancer Institute scientists say they have identified factors that predict improved response and survival in patients with head and neck cancers treated with checkpoint inhibitor immunotherapy. Two immunotherapy agents known as checkpoint inhibitors have been approved to treat patients whose disease is resistant to standard platinum-based chemotherapy. However, only a minority of …

View Post

Building “boot camps” for immune cells near tumors

In In The News by Barbara Jacoby

By: Alyssa Kneller From: Redington Newsdesk Novartis is collaborating with @wyssinstitute and @DanaFarber to develop devices with #cancer-fighting potential A new wave of therapies is unleashing the body’s immune system on cancer, significantly extending lives. These agents, however, don’t work for everyone, so scientists are exploring new approaches that might enable immunotherapies to more effectively combat tumors. One idea, born …

View Post

Stamford Hospital joins cancer collaborative

In In The News by Barbara Jacoby

From: stamfordadvocate.com The Stamford Hospital Carl & Dorothy Bennett Cancer Center is the newest member of the Dana-Farber/Brigham and Women’s Cancer Care Collaborative, and the first member from Connecticut. Participation in the collaborative reflects the Bennett Cancer Center’s demonstrated commitment to excellence by meeting a wide array of standards and best practices. As part of the membership process, the Dana-Farber/Brigham …

Why is cancer care failing?

In In The News by Barbara Jacoby

by: Shirie Leng, MD as seen on KevinMD.com The Institute of Medicine (IOM) recently released a report on the state of cancer care in the United States.  The IOM generally knows what it’s talking about.  It’s a non-profit, non-governmental advisory group essentially.  To get on one of their advisory boards you have to be a national, if not international, expert …